Justia Intellectual Property Opinion Summaries

by
EFF, a nonprofit organization that advocates in the public interest of consumers of digital technology, requested inter partes review of Personal Audio’s 504 Patent, entitled “System for Disseminating Media Content Representing Episodes in a Serialized Sequence.” The patent is directed to a system and apparatus for storing and distributing episodic media files (podcast technology). A podcast is a digital media file made available through web syndication, in which new installments or “episodes” are automatically received by subscribers. The 504 Patent claims an apparatus whose components receive and control playback of the episodes. The Patent Trial and Appeal Board found four claims unpatentable as anticipated under 35 U.S.C. 102 and/or obvious under 35 U.S.C. 103. The Federal Circuit affirmed, first holding that EFF is not constitutionally excluded from appearing in court to defend the PTAB decision in its favor. The court upheld the Board’s construction of “episode” as “a program segment, represented by one or more media files, which is part of a series of related segments, e.g., a radio show or a newscast,” its construction of “compilation file” as “a file that contains episode information,” and its holding that “updated version” did not require construction. View "Personal Audio, LLC v. Electronic Frontier Foundation." on Justia Law

by
Whirlpool’s 688 patent claims a household blender with a pre-programmed, automated blending cycle designed to blend items “quickly and reliably—by repeatedly dropping to a speed slow enough to allow the blender contents to settle around the cutter assembly, and then returning to a [higher] speed suitable for processing the contents.” It was well-known that a user could manually pulse between a high speed and a low speed to “achieve[] . . . a pattern of movement that introduces the entire contents of the reservoir into contact with the rotating blades” for efficient mixing,” so the claimed automatic blending routine was, in the prior art, done manually. There were also blenders on the market which allowed “preprogram[ing] ‘on-off’ sequence[s] [to] enable[] hands-free operation of the blender.” On inter partes review, the Patent Trial and Appeal Board did not construe the key term “settling speed” found in the claims and determined that the claims were not invalid as anticipated by prior art reference. The Federal Circuit reversed, employing the “broadest reasonable construction” of predetermined settling speed: a speed that is slower than the operating speed and permits settling of the blender contents, and concluding that the claims were anticipated. View "Homeland Housewares, LLC v. Whirlpool Corp." on Justia Law

by
The Respondents were the Protestant Episcopal Church in the Diocese of South Carolina (Disassociated Diocese); the Trustees of the Protestant Episcopal Church in South Carolina (Trustees); and thirty-six individual parishes that have aligned themselves with the Disassociated Diocese (Parishes). The Appellants were The Episcopal Church a/k/a The Protestant Episcopal Church in the United States of America (TEC) and The Episcopal Church in South Carolina, the diocese that remained affiliated with the TEC (Associated Diocese). This case was an appeal of a circuit court order holding that the Appellants have no legal or equitable interests in certain real and personal property located in South Carolina, and enjoining the Appellants from utilizing certain disputed service marks and names. “Overly simplified,” the issue in this case was whether the Disassociated Diocese, the Trustees, and the Parishes or appellant Associated Diocese and its parishes "owned" the real, personal, and intellectual property that the Appellants alleged was held in trust for the benefit of TEC in 2009. After a lengthy bench trial, and based upon the application of "neutral principles of law," the circuit court found in favor of the Respondents on property and the service mark causes of action. The circuit court order was reversed in part, and affirmed in part, with each South Carolina Supreme Court justice writing separately. Justice Hearn joined Acting Justice Pleicones and Chief Justice Beatty in reversing the trial court as to the twenty-nine parishes that documented their reaffirmation to the National Church. Chief Justice Beatty joined Acting Justice Toal and Justice Kittredge with respect to the remaining seven parishes. Four justices agreed the Dennis Canon created an enforceable trust, but Justice Kittredge disagreed with the majority and would have found the trust was revoked at the time of the schism. Moreover, though Acting Justice Pleicones and Justice Hearn believed ecclesiastical deference was required in this case, both opinions found all thirty-six parishes acceded to the Dennis Canon such that a legally cognizable trust was created in favor of the National Church. View "Protestant Episcopal Church v. Episcopal Church" on Justia Law

by
Honeywell’s 366 patent is directed to the use of 1,1,1,2-tetrafluoropropene, an unsaturated hydrofluorocarbon compound, and a polyalkylene glycol lubricant in heat transfer systems, such as air conditioning equipment. In merged inter partes examinations, an examiner rejected several claims under 35 U.S.C. 103. The Patent Trial and Appeal Board affirmed. The Federal Circuit vacated. The Board erred: by improperly relying on inherency to find obviousness and in its analysis of motivation to combine the references; in dismissing Honeywell’s evidence of unpredictability in the art when it stated that one of ordinary skill would no more have expected failure than success in combining the references; and in relying on a new grounds for rejection. View "Honeywell International, Inc. v. Mexichem Amanco Holding S.A." on Justia Law

by
Regeneron accused Merus of infringing the 018 patent. The district court issued an opinion construing various terms and declared one term indefinite. Merus asserted a counterclaim of unenforceability due to inequitable conduct. It argued that during prosecution of the patent, Regeneron’s patent prosecutors withheld four references that were cited in a third-party submission in related U.S. patent prosecution and in European opposition briefs, were but-for material, and were withheld by Regeneron with the specific intent to deceive. There was no dispute that Regeneron knew of the Withheld References during prosecution. Regeneron argued that the references were not but-for material, that they were cumulative of references actually relied-on during prosecution, and that Regeneron did not have any specific intent to deceive. The Federal Circuit affirmed the district court, which had “exhaustively detailed Regeneron’s discovery misconduct" throughout the litigation and sanctioned Regeneron by drawing an adverse inference of specific intent to deceive the PTO. The court noted Regeneron’s repeated violations of discovery orders and improper secreting of relevant and non-privileged documents. Regeneron committed inequitable conduct, rendering the patent unenforceable. View "Regeneron Pharmaceuticals, Inc. v. Merus N.V." on Justia Law

by
Kerry is the CEO of KEI, the son of Dale Earnhardt (a professional race car driver who died in 2001), and the stepson of Teresa. KEI's ventures include the EARNHARDT COLLECTION lifestyle brand. KEI licensed that mark to Schumacher for use in connection with custom home design and construction. Teresa, Dale's widow, owns trademark registrations and common law rights containing the mark DALE EARNHARDT in connection with various goods and services and has sold licensed merchandise totaling millions of dollars since 2001. Teresa filed notices of opposition to KEI's trademark application. The Trademark Board found that Teresa did not establish a likelihood of confusion and that EARNHARDT COLLECTION is not primarily merely a surname, 15 U.S.C. 1052(e)(4). The Board found that “collection” is “not the common descriptive or generic name” for KEI’s goods and services. The Federal Circuit vacated. The Board's decision could be understood as finding that “collection” is neither generic nor merely descriptive of KEI’s goods and services, and adding “collection” to “Earnhardt” alters the surname significance of Earnhardt in the mark as a whole; it could be understood as finding that a mark consisting of a surname and a merely descriptive term is registrable as a matter of law if the descriptive term is not generic. View "Earnhardt v. Kerry Earnhardt, Inc." on Justia Law

by
The specifications of the three Soft Gel patents describe a method for dissolving CoQ10. The patented inventions include a composition, a soft gelatin capsule, and a method of making such a soft gelatin capsule, each involving a solution of CoQ10 dissolved in a monoterpene. CoQ10, also called ubiquinone, is a coenzyme, i.e., a chemical compound that is required for the biological activity of certain proteins and is necessary for certain metabolic processes and for the production of cellular energy; it has a secondary role as an antioxidant. In clinical trials, CoQ10 has been shown to be effective in regulating blood pressure and cholesterol levels, improving cardiovascular health, and “thwarting various diseases such as certain types of cancers.” It is “sparingly soluble in hydrophilic solvents such as water.” According to the patents, at the time of the inventions, most solvents that were used to administer CoQ10 in liquid form could dissolve, at most, only about 5 to 10 percent of the CoQ10. Jarrow requested inter partes reexaminations of the three Soft Gel patents. The Patent Board invalidated several claims. The Federal Circuit affirmed, finding the claims invalid as obvious in light of prior references, 35 U.S.C. 103(a). View "Soft Gel Technologies, Inc. v. Jarrow Formulas, Inc." on Justia Law

by
NobelBiz alleged infringement of patents titled “System and method for modifying communication information” with identical specifications. The patents relate to “a method for processing a communication between a first party and a second party.” When a call originator contacts a call target, the system modifies the caller ID data “to provide a callback number or other contact information . . . that may be closer to or local to the Target.” The Federal Circuit reversed a jury verdict of infringement, stating that the district court erred in its claim construction. The intrinsic evidence better supports the defendants’ proposed construction: “outbound call” should be construed as a “call placed by an originator to a target.” View "NobelBiz, Inc. v. Global Connect, L.L.C." on Justia Law

by
Parks was founded in the 1950s and was the first African-American-owned company to be publicly traded on the NYSE. Parks engaged in radio and television advertising, using a well-known slogan, “More Parks Sausages, Mom, Please.” Though the PARKS brand had likely developed prominence sufficient for common law trademark protection before 1970, the name was not registered in the Patent and Trademark Office until 1970. In the early 2000s, Parks failed to renew the registration. Following the death of its owner, the company had fallen on hard times and had licensed the production and sale of its products. In 2014, Tyson, the owner of the BALL PARK brand, launched a premium frankfurter product called PARK’S FINEST. Parks sued, alleging false advertising and trademark infringement. The district court determined that the false advertising claim was a repetition of the trademark claim and that the PARKS mark was too weak to merit protection against Tyson’s use of PARK’S FINEST. The Third Circuit affirmed. The fact that the PARKS mark has existed for a long time and that it enjoyed secondary meaning half a century ago cannot overcome the factors against Parks. There is almost no direct-to-consumer advertising; Parks has a minuscule market share, and there is practically no record of actual confusion. View "Parks LLC v. Tyson Foods Inc" on Justia Law

by
Millennium developed the patented product for the treatment of oncology diseases, particularly multiple myeloma and mantle cell lymphoma. The product has the brand name Velcade®. Sandoz and others filed abbreviated new drug applications (ANDAs), admitting infringement and seeking to invalidate various claims of the 446 Patent. The district courts held that certain claims were invalid as obvious, 35 U.S.C. 103. In consolidated appeals, the Federal Circuit concluded that the district court erred and that invalidity was not established. Sandoz identified no reference or combination of references that show or suggest a reason to make the claimed compound. The district court clearly erred in its examination of the objective indicia of unexpected results and long-felt need. View "Millenium Pharmaceuticals, Inc. v. Sandoz, Inc." on Justia Law